A Chinese laboratory has been developing a drug with the aim that the drug has the power to bring the pandemic to a halt.
The said drug being is tested by scientists at Peking University, China, that could not only shorten the recovery time for infected COVID-19 patients, but also offer a short-term immunity from the virus.
Sunney Xie, director of the university’s Beijing, told AFP that the drug has successfully cleared the animal testing stage.
“When we injected neutralizing antibodies into infected mice, after five days the viral load was reduced by a factor of 2, 500,” said Xie.
The drug has a number of neutralizing antibodies – which Xie’s team isolated from the blood of 60 recovered patients – produced to prevent the growth of virus infecting cells.
Sunney Xie added that the drug will be ready by the end of this year, while the clinical trial, which will be carried out in Australia and other countries, is underway.
Reportedly, more than 100 vaccines for Covid-19 are working globally, and in China, five potential coronavirus vaccines are already at the human trial stage, but according to the World Health Organization, developing a vaccine could take 12 to 18 months.
Xie is hoping that the new drug could become a faster and efficient way to stop the global march of the coronavirus.
He said, “We would be able to stop the pandemic with an effective drug, even without a vaccine”.